They Kaye Competition awards $1-million a year to innovative health-care research projects at the University of Alberta Hospital. Last year, one of the projects to receive funding was Dr. Andrea Haqq’s research into how semaglutide, prescribed under the brand names Ozempic and Wegovy, affects energy expenditure in people with Type 2 diabetes and obesity.
Global News Hour at 6 Edmonton
Kaye Competition accepting applications for innovative health-care projects
More Videos
-
First look inside Maisie’s Magical Christmas House
-
Alberta government creates homelessness advisory panel
-
Edmonton businesses feeling tax holiday impact
-
Former soldier with PTSD killed inside Edmonton jail
-
Global News Hour at 6 Edmonton: Dec.20
-
Edmonton airport’s busiest travel days ahead of the holidays
You are viewing an Accelerated Mobile Webpage.
View Original Article